AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...

Daiichi Sankyo has announced that Hiroyuki Okuzawa will succeed Sunao Manabe as chief executive officer from 1 April 2025.

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

During a Senate HELP Committee hearing, RFK Jr. stated that President Trump is dedicated to bringing drug manufacturing "back ...

Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.

The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.